Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral disintegrating preparation containing tegafur, gimeracil and potassium oxonate

A technology of oral disintegration and tegafur, which is applied in the directions of pill delivery, active ingredients of heterocyclic compounds, and drug combinations, can solve the problems of inconvenient industrialized production, complex production process, poor water solubility, etc. The preparation process is simple and the effect of reducing irritation

Inactive Publication Date: 2015-08-19
SHANDONG NEWTIME PHARMA
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] CN101574326A discloses a capsule preparation of S-1 and its preparation method. This invention improves the stability of S-1, but the dissolution rate of the drug has not been improved. In order to ensure rapid dissolution, a large amount of surfactant has been added. The minimum dosage reaches 10mg / capsule, which is more irritating to the gastrointestinal tract. At the same time, the pellet coating technology is adopted, and the production process in the workshop is complicated.
[0006] CN1660105A discloses a prescription and preparation process of S-1 orally disintegrating tablets, which can cover up the bad bitter taste of the medicine, but the water solubility of the medicine has not been improved
CN101843621A discloses a kind of tigio granule, which is solved by making the active ingredient of the drug into a cyclodextrin inclusion compound to improve the dissolution rate and bioavailability of the drug. However, the cyclodextrin inclusion process is relatively complicated, and the workshop industry Chemical production has many inconveniences
[0009] Tegafur is an alkaline drug with poor water solubility and shows instability in acidic solution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral disintegrating preparation containing tegafur, gimeracil and potassium oxonate
  • Oral disintegrating preparation containing tegafur, gimeracil and potassium oxonate
  • Oral disintegrating preparation containing tegafur, gimeracil and potassium oxonate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] prescription:

[0026]

[0027]

[0028] Preparation:

[0029] Tegafur, gemostat and oteracil potassium pass through a 100-mesh sieve, carbohydrates, disintegrants and flavoring agents pass through a 80-mesh sieve, mix well, add appropriate amount of distilled water, granulate and dry, and granulate with a 20-mesh sieve , and then add the prescribed amount of lubricant, mix well, and press into tablets.

Embodiment 2

[0031] prescription:

[0032]

[0033] Preparation:

[0034] Tegafur, gemostat and oteracil potassium pass through a 100-mesh sieve, carbohydrates, disintegrants and flavoring agents pass through a 80-mesh sieve, mix well, add appropriate amount of distilled water, granulate and dry, and granulate with a 20-mesh sieve , and then add the prescribed amount of lubricant, mix well, and press into tablets.

Embodiment 3

[0036] prescription:

[0037]

[0038]

[0039] Preparation:

[0040] Tegafur, gemostat and oteracil potassium pass through a 100-mesh sieve, carbohydrates, disintegrants and flavoring agents pass through a 80-mesh sieve, mix well, add appropriate amount of distilled water, granulate and dry, and granulate with a 20-mesh sieve , and then add the prescribed amount of lubricant, mix well, and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an oral disintegrating preparation containing tegafur, gimeracil and oteracil potassium. The oral disintegrating preparation also includes carbohydrates and a disintegrating agent. Active ingredients in the oral disintegrating preparation are high in dissolution rate so that a drug is ensured to work quickly. More importantly, the oral disintegrating preparation is good in stability, is free of surfactants, is reduced in irritation to human gastrointestinal tract and improves patient compliance. The oral disintegrating preparation is simple in preparation technology and is suitable for industrial production.

Description

[0001] This application is a divisional application with the application number CN201410418922.4, the application date is 2014.08.22, and the title of the invention is an orally disintegrating preparation containing tegafur, gimester and oteracil potassium. technical field [0002] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to an orally disintegrating preparation containing tegafur, gimester and oteracil potassium. Background technique [0003] Tegafur (FT, FT207) is one of the pyrimidine anticancer drugs. It is the prodrug of 5-fluorouracil (5-FU), and has inhibitory effect on most solid tumors. In the body, it can interfere and block the biosynthesis of DNA, RNA and protein, thereby producing its anticancer effect. Basic medical research and clinical observation have proved that tegafur has less toxic and side effects, higher chemotherapy index, less impact on immunosuppression and related immune organs, and is a ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/53A61K9/20A61P35/00A61K31/4412A61K31/513
Inventor 张贵民
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products